642 related articles for article (PubMed ID: 9610707)
21. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.
Montironi R; Lucarini G; Castaldini C; Galluzzi CM; Biagini G; Fabris G
Anticancer Res; 1996; 16(4A):2057-62. PubMed ID: 8712742
[TBL] [Abstract][Full Text] [Related]
23. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy.
Weinstein MH; Epstein JI
Hum Pathol; 1993 Jun; 24(6):624-9. PubMed ID: 7684999
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia.
Humphrey PA; Swanson PE
Pathol Res Pract; 1995 Sep; 191(9):881-7. PubMed ID: 8606869
[TBL] [Abstract][Full Text] [Related]
25. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
26. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
Kronz JD; Shaikh AA; Epstein JI
Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
[TBL] [Abstract][Full Text] [Related]
27. Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.
Hampel OZ; Kattan MW; Yang G; Haidacher SJ; Saleh GY; Thompson TC; Wheeler TM; Marcelli M
J Urol; 1998 Jun; 159(6):2220-5. PubMed ID: 9598573
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
[TBL] [Abstract][Full Text] [Related]
29. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Sauvageot J; Epstein JI
Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
[TBL] [Abstract][Full Text] [Related]
30. Prostatic intraepithelial neoplasia and well differentiated adenocarcinoma maintain an intact basement membrane.
Bostwick DG; Leske DA; Qian J; Sinha AA
Pathol Res Pract; 1995 Sep; 191(9):850-5. PubMed ID: 8606864
[TBL] [Abstract][Full Text] [Related]
31. Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration.
Alexander EE; Qian J; Wollan PC; Myers RP; Bostwick DG
Urology; 1996 May; 47(5):693-8. PubMed ID: 8650867
[TBL] [Abstract][Full Text] [Related]
32. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy.
Kronz JD; Allan CH; Shaikh AA; Epstein JI
Am J Surg Pathol; 2001 Aug; 25(8):1079-85. PubMed ID: 11474294
[TBL] [Abstract][Full Text] [Related]
33. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic bodies in prostatic intraepithelial neoplasia and prostatic adenocarcinoma following total androgen ablation.
Montironi R; Magi-Galluzzi C; Fabris G
Pathol Res Pract; 1995 Sep; 191(9):873-80. PubMed ID: 8606868
[TBL] [Abstract][Full Text] [Related]
35. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
Koutsilieris M; Lembessis P; Luu-The V; Sourla A
Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
[TBL] [Abstract][Full Text] [Related]
36. Digital image analysis of proliferative index: two distinct populations of high-grade prostatic intraepithelial neoplasia in close proximity to adenocarcinoma of the prostate.
Weinstein MH
Hum Pathol; 1998 Jun; 29(6):620-6. PubMed ID: 9635684
[TBL] [Abstract][Full Text] [Related]
37. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
[TBL] [Abstract][Full Text] [Related]
38. Atypical cribriform lesions on prostate biopsy.
Kronz JD; Shaikh AA; Epstein JI
Am J Surg Pathol; 2001 Feb; 25(2):147-55. PubMed ID: 11176063
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer.
Dawson DM; Lawrence EG; MacLennan GT; Amini SB; Kung HJ; Robinson D; Resnick MI; Kursh ED; Pretlow TP; Pretlow TG
J Natl Cancer Inst; 1998 Apr; 90(7):519-23. PubMed ID: 9539247
[TBL] [Abstract][Full Text] [Related]
40. Changes in biomarker expression in the development of prostatic adenocarcinoma.
Myers RB; Grizzle WE
Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
